Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma
Clinical trial NCT00007956 · COMPLETED
Trial details
- NCT number
- NCT00007956
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.